Perrigo (PRGO) Invested Capital (2013 - 2026)
Perrigo's (PRGO) quarterly Invested Capital came in at $11.4 million in Q1 2026, down 68.51% year-on-year from $36.2 million in Q1 2025, and down 68.85% on a QoQ basis from $36.6 million in Q4 2025.
Perrigo (PRGO) Invested Capital (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Invested Capital data on file, last reported at $11.4 million in Q1 2026.
- On a quarterly basis, Invested Capital fell 68.51% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $121.0 million, a 87.32% decrease from a year earlier, with the FY2025 full-year figure at $36.6 million, up 0.55% from the prior year.
- Invested Capital for Q1 2026 stood at $11.4 million, down from $36.6 million in the prior quarter.
- Over the last five years, Invested Capital for PRGO reached as high as $440.8 million in Q2 2024 and fell as low as $4.6 million in Q2 2022.
- Historically, Invested Capital has averaged $128.0 million across 5 years, with a median of $36.6 million in 2025.
- Across the five-year window, Invested Capital sank 95.11% in 2022 and surged 1117.13% in 2023, its largest moves.
- Year by year, Invested Capital stood at $36.2 million in 2022, then jumped by 1117.13% to $440.6 million in 2023, then plunged by 91.74% to $36.4 million in 2024, then advanced by 0.55% to $36.6 million in 2025, then tumbled by 68.85% to $11.4 million in 2026.
- Per Business Quant data, the three most recent Invested Capital figures were $11.4 million in Q1 2026, $36.6 million in Q4 2025, and $36.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 11.40 Mn |
| Dec 31, 2025 | 36.60 Mn |
| Sep 27, 2025 | 36.60 Mn |
| Jun 28, 2025 | 36.40 Mn |
| Mar 29, 2025 | 36.20 Mn |
| Dec 31, 2024 | 36.40 Mn |
| Sep 28, 2024 | 440.70 Mn |
| Jun 29, 2024 | 440.80 Mn |
| Mar 30, 2024 | 440.60 Mn |
| Dec 31, 2023 | 440.60 Mn |
| Sep 30, 2023 | 38.10 Mn |
| Jul 1, 2023 | 38.40 Mn |
| Apr 1, 2023 | 38.80 Mn |
| Dec 31, 2022 | 36.20 Mn |
| Oct 1, 2022 | 33.50 Mn |
| Jul 2, 2022 | 30.80 Mn |
| Apr 2, 2022 | 4.60 Mn |
| Dec 31, 2021 | 603.80 Mn |
| Oct 2, 2021 | 629.40 Mn |
| Jul 3, 2021 | 630.10 Mn |